Mitsubishi's Radicava ready to roll with ALS nod by Eric Sagonowsky Monday, May 8, 2017 The FDA actually invited Mitsubishi Tanabe to file Radicava for U.S. approval based on data generated in Japan. Now, it's the first new ALS med in decades.
